«OXELADIN» 관련 폴란드어 책
다음 도서 목록 항목에서
oxeladin 의 용법을 확인하세요.
oxeladin 에 관련된 책과 해당 책의 짧은 발췌문을 통해 폴란드어 서적에서 단어가 사용되는 맥락을 제공합니다.
1
Consolidated List of Products Whose Consumption And/or Sale Have ...
(Reference: (DEURFI) Rapid Alert - Pharmacovigilance, , , 14 Mar 1995) FRA 19 Apr 1995 Since the results of the German study on the potential carcinogenicity of oxeladin were disseminated, the Medicinal Products Agency has recalled all ...
2
Hagers Handbuch der Pharmazeutischen Praxis: Band 8: Stoffe E-O
... mit ßß-Dichlordiethylether [Bis (2 Chlorethyl)ether] erfolgt im natronalkal Miheu Rkt zum a,a-Diphenylessigsaure 2-(ßchlorethoxy)-ethylester (4), der mit Diethylamin Oxeladin liefert Kle82 l CN + 2 C2H30| (1) (2) H502 Сгнз Na/NH3 fi __P CN ...
Franz v. Bruchhausen, Gerd Dannhardt, Siegfried Ebel, 2013
3
Pharmaceutical substances: syntheses, patents, applications
Oxeladin. ATC: R05DB09 Use: antitussive RN: 468-61-1 MF: C^HjjNOj MW: 335.49 EINECS: 207-418-4 LD»: 13 mg/kg (M, i.v.); 130 mg/kg (M, p.o.); 183mg/kg(R, p.o.) CN: a,a-diethylbenzeneacetic acid 2-[2-(diethylamino)ethoxy]ethyl ester ...
Axel Kleemann, Jürgen Engel, 2001
4
Český lékopis 2009 – Doplněk 2013: - Strona 9052
... peak identification Oxeladin-citrát Oxeladin hydrogen citrate Oxeladin nečistota C Oxeladin impurity C Oxeladin nečistota D Oxeladin impurity D Oxfendazol nečistota B Oxfendazole impurity B Oxfendazol pro veterinární použití Oxfendazole ...
Ministerstvo zdravotnictví ČR, 2013
5
Antitussive agents - Tom 2 - Strona 591
(c) Miscellaneous activity Large doses of oxeladin (larger than 0.1 mg/kg) produced reduction in amplitude of normal rhythmic contraction in the isolated rabbit duodenum. It has 1/600 of the activity of methantheline bromide against ...
Harry Salem, Domingo M. Aviado, 1970
6
Clarke's Isolation and Identification of Drugs in Pharmaceuticals, ...
Oxeladin Citrate Proprietary Names. Dorex-retard ; Paxeladine. C.oHjjNOj.QHjO^ 527.6 CAS— 52432-72-1 A white crystalline powder. M.p. 90° to 91°. Soluble in water. Colour Test. Marquis Test — orange. Thin-layer Chromatography.
Eustace George Coverley Clarke, A. C. Moffat, Pharmaceutical Society of Great Britain. Dept. of Pharmaceutical Sciences, 1986
7
Essentials of Pharmacology for Dentistry - Strona 284
Oxeladin Another synthetic centrally acting antitussive, devoid of opioid side effects. Chlophediano! It is similar to oxeladin, has a slow onset and longer duration of antitussive action. Side effect: Dryness of mouth, vertigo, irritability.
8
Ullmann's encyclopedia of industrial chemistry - Tom 11 - Strona 18
Trade Names. Atussil (Squibb), Gcrmapect (Thiemann), Sedotussin (UCB), Toclase (Pfizer, Sumitomo), Tuclase (UCB). Oxeladin [468-61-1], 2-(2-diethylamino- ethoxy)ethyl 3-phenyl-3-pentanecarboxylate, C20H33NO3, M, 335.47, bp 140 °C ...
Fritz Ullmann, Wolfgang Gerhartz, Y. Stephen Yamamoto, 1987
9
Pharmaceuticals: Neuropharmaceuticals, Gastrointestinal drugs, ...
sil (Squibb), Germapect (Thiemann), Sedotussin (UCB), Toclase (Pfizer. Sumitomo), Tuclase (UCB). Oxeladin [468-61-1], 2-(2-diethylaminoethoxy)ethyl 3-phenyl-3-pentanecarboxylate, C20H23NO3, M, 335.47, bp 140 °C ...
10
The Extra Pharmacopoeia: "Amendments" ( 2 l.) inserted - Strona 936
Oxeladin Citrate. 2-(2-Diethylaminoethoxy)ethyl diethylphenylacetate dihydrogen citrate. C,0HajOjN,C,H,O7= 527-6. Dose: 10 to 20 mg. (*/« to '/a grain) four times daily; 5 to 10 mg. ('/,, to '/6 grain) for children. Uses. Oxeladin is an antitussive ...
